Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Neil H Bhola

2PUBLICATIONS
17CO-AUTHORS
Biologically active moleculesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Sep 04, 2023
Discovery and Characterization of ZL-2201, a Potent, Highly Selective, and Orally Bioavailable Small-molecule DNA-PK Inhibitor.

Shruti Lal, Neil E Bhola, Bee-Chun Sun

|Jun 02, 2017
Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in <i>RAS</i> mutant cancers.

Chaoyang Sun, Yong Fang, Jun Yin

Pageof 1

Frequent Collaborators

1 joint publications

Shruti Lal

1 joint publications

Bee-Chun Sun

1 joint publications

Yuping Chen

1 joint publications

Tom Huang

1 joint publications

Vivian Morton

1 joint publications

Kevin X Chen

1 joint publications

Shanghua Xia

1 joint publications

Haoyu Zhang

1 joint publications

Nehal S Parikh

1 joint publications

Qiuping Ye

Frequent Collaborators

1 joint publications

Shruti Lal

1 joint publications

Bee-Chun Sun

1 joint publications

Yuping Chen

1 joint publications

Tom Huang

Top Related Videos

Identification of Mediators of T-cell Receptor Signaling <em>via</em> the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling <em>via</em> the Screening of Chemical Inhibitor Libraries

Published on : Jan 22, 2019

9.2K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

8.0K
See more related videos

Top Related Videos

Identification of Mediators of T-cell Receptor Signaling <em>via</em> the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling <em>via</em> the Screening of Chemical Inhibitor Libraries

Published on : Jan 22, 2019

9.2K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

8.0K
See more related videos